Search for: "Mylan, Inc."
Results 1 - 20
of 587
Sort by Relevance
|
Sort by Date
25 Nov 2024, 1:12 pm
While there, she prosecuted many notable FCA cases including several qui tam cases against National Medicare Care, Inc. [read post]
30 Aug 2024, 3:00 am
” In re Mylan N.V. [read post]
6 Aug 2024, 1:53 pm
(“Novartis”), as well as Viatris Inc. and its subsidiary Mylan Pharmaceuticals, in the United States District Court for the District of Maryland. [read post]
29 May 2024, 11:27 am
Mylan Pharmaceuticals Inc., Case No. 1:22-CV61 (KLEEH) (N.D. [read post]
24 Apr 2024, 4:52 am
For example, Mylan and Mallinckrodt settled significant cases alleging Medicaid rebate fraud brought by our whistleblower clients. [read post]
9 Apr 2024, 2:56 pm
Proc. 97-35, and cases like RJR Nabisco, Inc. v. [read post]
1 Apr 2024, 10:58 am
., Inc. v. [read post]
13 Mar 2024, 7:24 pm
., Inc. v. [read post]
9 Feb 2024, 11:08 am
” Similarly, as show in the Mylan Laby’s, Inc. v. [read post]
22 Jan 2024, 9:00 am
Mylan Labs, Inc., 2. [read post]
14 Jan 2024, 9:29 pm
Mylan Pharmaceuticals Inc. [read post]
2 Jan 2024, 8:45 pm
Mylan Pharmaceuticals Inc. [read post]
18 Dec 2023, 9:07 pm
Mylan Pharmaceuticals Inc. [read post]
13 Dec 2023, 8:25 pm
Mylan Pharmaceuticals Inc. [read post]
7 Dec 2023, 9:59 pm
Mylan Pharmaceuticals Inc., with the Court vacating and remanding the District Court's claim construction for failure to consider extrinsic evidence. [read post]
6 Nov 2023, 1:15 pm
Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. [read post]
6 Nov 2023, 1:15 pm
Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. [read post]
6 Nov 2023, 8:35 am
Mylan Pharmaceuticals Inc., No. 2022-1889 (Fed. [read post]
2 Aug 2023, 11:05 am
Sanofi argued on appeal that the Board erroneously agreed with Mylan’s argument that de Gennes constituted analogous art because Mylan incorrectly compared the de Gennes reference to another prior art reference, and not the ’614 patent. [read post]
25 May 2023, 6:00 am
Mylan Pharmaceuticals Inc., No. 2021-1981, 2023 U.S. [read post]